BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31829945)

  • 1. Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina.
    Salgado MV; Coxson P; Konfino J; Penko J; Irazola VE; Gutiérrez L; Fernández A; Mejía R
    Medicina (B Aires); 2019; 79(6):438-444. PubMed ID: 31829945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina.
    Konfino J; Mekonnen TA; Coxson PG; Ferrante D; Bibbins-Domingo K
    PLoS One; 2013; 8(9):e73824. PubMed ID: 24040085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law.
    Konfino J; Ferrante D; Mejia R; Coxson P; Moran A; Goldman L; Pérez-Stable EJ
    Tob Control; 2014 Mar; 23(2):e6. PubMed ID: 23092886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the impact of plain packaging of tobacco products on cardiovascular disease in Argentina.
    Salgado MV; Penko J; Fernandez A; Mejia R
    Tob Control; 2023 Mar; 32(2):255-258. PubMed ID: 34261789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected impact of a reduction in sugar-sweetened beverage consumption on diabetes and cardiovascular disease in Argentina: A modeling study.
    Salgado MV; Penko J; Fernandez A; Konfino J; Coxson PG; Bibbins-Domingo K; Mejia R
    PLoS Med; 2020 Jul; 17(7):e1003224. PubMed ID: 32722677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.
    Sánchez-Romero LM; Penko J; Coxson PG; Fernández A; Mason A; Moran AE; Ávila-Burgos L; Odden M; Barquera S; Bibbins-Domingo K
    PLoS Med; 2016 Nov; 13(11):e1002158. PubMed ID: 27802278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.
    Pandya A; Sy S; Cho S; Alam S; Weinstein MC; Gaziano TA
    Med Decis Making; 2017 Oct; 37(7):802-814. PubMed ID: 28490271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.
    Moran A; Zhao D; Gu D; Coxson P; Chen CS; Cheng J; Liu J; He J; Goldman L
    BMC Public Health; 2008 Nov; 8():394. PubMed ID: 19036167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacto sanitario de la prohibición total de publicidades de tabaco en argentina.
    Konfino J; Salgado MV; Penko J; Coxson P; Fernández A; Pichon-Riviere A; Bibbins-Domingo K; Mejía R
    Glob Health Promot; 2022 Apr; ():17579759221079603. PubMed ID: 35440241
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a Synthetic Population Model for Assessing Excess Risk for Cardiovascular Disease Death.
    Krauland MG; Frankeny RJ; Lewis J; Brink L; Hulsey EG; Roberts MS; Hacker KA
    JAMA Netw Open; 2020 Sep; 3(9):e2015047. PubMed ID: 32870312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?
    Ortendahl JD; Diamant AL; Toth PP; Cherepanov D; Harmon AL; Broder MS
    Clin Cardiol; 2019 Jan; 42(1):47-55. PubMed ID: 30318600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projected age- and sex-specific prevalence of cardiovascular diseases in Western Australian adults from 2005-2045.
    Sarink D; Nedkoff L; Briffa T; Shaw JE; Magliano DJ; Stevenson C; Mannan H; Knuiman M; Peeters A
    Eur J Prev Cardiol; 2016 Jan; 23(1):23-32. PubMed ID: 25305272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for recurrent cardiovascular disease in middle-eastern adults: a retrospective study.
    Govender RD; Al-Shamsi S; Soteriades ES; Regmi D
    BMC Cardiovasc Disord; 2019 Nov; 19(1):253. PubMed ID: 31711429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
    Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics.
    Backholer K; Hirakawa Y; Tonkin A; Giles G; Magliano DJ; Colagiuri S; Harris M; Mitchell P; Nelson M; Shaw JE; Simmons D; Simons L; Taylor A; Harding J; Gopinath B; Woodward M
    BMC Cardiovasc Disord; 2017 Jan; 17(1):17. PubMed ID: 28061760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
    Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
    Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statistics.
    Lopez AD; Adair T
    Int J Epidemiol; 2019 Dec; 48(6):1815-1823. PubMed ID: 31378814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
    Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
    Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project.
    Hata J; Nagai A; Hirata M; Kamatani Y; Tamakoshi A; Yamagata Z; Muto K; Matsuda K; Kubo M; Nakamura Y; ; Kiyohara Y; Ninomiya T
    J Epidemiol; 2017 Mar; 27(3S):S71-S76. PubMed ID: 28142037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.
    Marques-Vidal P; Rodondi N; Bochud M; Pécoud A; Hayoz D; Paccaud F; Mooser V; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):402-8. PubMed ID: 18677163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.